Thread on #Laurus Labs
Having Market Capitalization of 14247 cr , laurus labs is a vertical integrated pharma company operating across three segments –APIs, formulations and (CDMO).
It provides CDMO services to 4 out of top 10 big pharma companies and several biotech company
Having Market Capitalization of 14247 cr , laurus labs is a vertical integrated pharma company operating across three segments –APIs, formulations and (CDMO).
It provides CDMO services to 4 out of top 10 big pharma companies and several biotech company
Laurus has demonstrated commendable execution capability in this segment growing 165x from 5 crore to 825 crore in FY18-20 .
In order to supplement future growth, a 300+crore capex plan is already under way to increase current capacity by 1.8x by H2FY22E.
In order to supplement future growth, a 300+crore capex plan is already under way to increase current capacity by 1.8x by H2FY22E.
R&D spend for FY20 was at 160 crore (5.7% of revenues). The company is further investing R&D to develop manufacture products across multiple therapies in a cost effective manner.
There are 750+ scientists (including 40+ PhDs) dedicated to R&D.
There are 750+ scientists (including 40+ PhDs) dedicated to R&D.
Company is driven by strong order book visibility, improving margin profile, strengthening return ratios and healthy FCF generation.
For long term , this is very good recommendation in API sector.
@Rishikesh_ADX @punitbansal14 @AnyBodyCanFly @Jitendra_stock @unseenvalue
For long term , this is very good recommendation in API sector.
@Rishikesh_ADX @punitbansal14 @AnyBodyCanFly @Jitendra_stock @unseenvalue
• • •
Missing some Tweet in this thread? You can try to
force a refresh
